Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-31 @ 6:36 PM
Study NCT ID:
NCT06317805
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Sponsor:
AOP Orphan Pharmaceuticals AG
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TREV1-10P.401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None